Skip to content
BillHelp
Menu
YOUR BILLHELP GUIDE

Genetic Testing Denied by a Health Plan

What can I do if a health plan denies genetic testing?

A plan can deny genetic testing as not medically necessary, as missing an approval, or because the laboratory is out of network. Some BRCA counseling and testing for eligible women is a preventive service with no cost sharing. A federal law, GINA, limits how health plans and employers may use genetic information. It does not require a plan to pay for a test. This page explains the appeal and those limits. It does not promise coverage.

Get help with my bill →
General U.S. guidance. Your plan documents and denial notice explain the process that applies to your case. Medicare, Medicaid, and other programs may use different rules. This is not medical or legal advice, and no result is guaranteed.

Why do plans deny genetic testing?

The points below were checked on the U.S. Preventive Services Task Force, HealthCare.gov, eCFR, the Departments of Labor, Health and Human Services, and the Treasury, and the National Human Genome Research Institute on November 14, 2026. Your denial notice controls the reason and the deadline.

Read the notice before you choose a response. Not medically necessary, investigational or experimental, missing prior authorization, and an out-of-network laboratory are different reasons. A medical-necessity denial is in a medical-necessity denial. An experimental or investigational denial is in an experimental treatment denial. A missing approval is in a prior authorization denial. The laboratory that ran the test and the clinician who ordered it may be different organizations. Compare the bill with the explanation of benefits, and confirm the laboratory's name and whether it is in network. See a lab test the plan did not cover and an out-of-network medical bill. Do not start or cancel a test based on this page. Ask the ordering clinician what the result would change.

A laboratory bill is not the plan's decision. If you have only a bill, ask the plan for the written denial or the explanation of benefits. How those documents differ is in how an explanation of benefits differs from a bill. If the explanation says the plan paid nothing because the test is not a benefit, that is a coverage question. If it says you owe an out-of-network amount, that is a network question. Answer the reason the notice actually gives.

References: HealthCare.gov: Internal appeals

When is BRCA counseling or testing preventive care with no cost sharing?

The current U.S. Preventive Services Task Force recommendation on BRCA-related cancer is dated August 20, 2019. It gives a B recommendation for women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer, or an ancestry associated with BRCA1 or BRCA2 gene mutations. For that group, the Task Force recommends that primary care clinicians assess the woman with an appropriate brief familial risk assessment tool. Women with a positive result on that tool should receive genetic counseling and, if indicated after counseling, genetic testing. The Task Force gives a D recommendation against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1 or BRCA2 mutations. The recommendation is about women and about BRCA1 and BRCA2. It is not a rule that every genetic test, for every person, is preventive care. A test of a different gene, or a test for a man, is a medical-necessity or plan-benefit question, not this B recommendation. The Task Force page for this topic says the recommendation is being updated, and the August 20, 2019 recommendation is still the current final one.

45 CFR 147.130 says a group health plan, or a health insurance issuer offering group or individual health insurance coverage, must cover without cost sharing the items and services that have an A or B rating in the current recommendations of the U.S. Preventive Services Task Force for the person involved. The B recommendation above is that kind of service for a woman who meets it. The D recommendation is not. A grandfathered plan is generally outside this no-cost rule. HealthCare.gov's list of preventive services for women includes breast cancer genetic test counseling (BRCA) for women at higher risk. HealthCare.gov says these services are generally covered at no cost when an in-network provider gives them, and that a cost of zero is not guaranteed in all cases. A grandfathered plan, an out-of-network provider, and a problem addressed during the same visit can each change what you owe. Those limits are in a bill for preventive care.

A joint FAQ from the Departments of Labor, Health and Human Services, and the Treasury, ACA implementation Part 26, says the Departments' view is that the BRCA recommendation includes both genetic counseling and BRCA testing, if appropriate, for a woman as determined by her health care provider. The FAQ answers yes to coverage without cost sharing for a woman who has not been diagnosed with BRCA-related cancer, including a woman who previously had breast cancer, ovarian cancer, or other cancer, when the screening, counseling, and testing are appropriate as determined by her attending provider. The FAQ quotes an earlier Task Force wording. The current recommendation statement is the August 20, 2019 statement in the paragraph above. Use that statement for who is in the population, and use the FAQ for the Departments' statement that testing, not only counseling, is included when it is appropriate. If the plan denied the test as diagnostic or not preventive, ask it to say whether you are in that population and whether the provider is in network. Appeal if the notice tells you how. See how to appeal a health insurance denial.

References: USPSTF: BRCA-related cancer risk assessment, genetic counseling, and genetic testing · 45 CFR 147.130, Coverage of preventive health services · HealthCare.gov: Preventive care benefits for women · DOL, HHS, and Treasury: ACA FAQ Part 26, including BRCA counseling and testing

What does GINA actually cover?

GINA is not a coverage mandate. The Department of Labor's questions on Title I of the Genetic Information Nondiscrimination Act describe group health plans. A group health plan cannot adjust premium or contribution amounts for the plan, or for a group of similarly situated people, based on genetic information. GINA generally prohibits a plan from requesting or requiring an individual to undergo a genetic test. A health care professional who is providing care may request a genetic test. A plan may request the results of a genetic test to decide payment of a claim, but only the minimum information necessary for that payment decision. A plan may not collect genetic information, including family medical history, before or in connection with enrollment, or for underwriting. The Department of Labor says information about a manifested disease of a person enrolled in the plan is not genetic information with respect to that person. A plan may increase the group's premium based on a manifested disease. A person who has a genetic result showing a higher risk, but who has no signs or symptoms and has not been and could not reasonably be diagnosed with the disease, does not have a manifested disease.

That payment sentence is the limit that matters on a denied test. GINA does not say the plan must pay for genetic testing. A denial that the test is not medically necessary, not a benefit, or out of network is a coverage decision. Appeal that decision. Do not send the plan a letter that says only that GINA requires payment. The National Human Genome Research Institute, part of the National Institutes of Health, says Title I of GINA is health insurance and Title II is employment. It says the health insurance protections do not cover long-term care insurance, life insurance, or disability insurance, and that some states have additional laws. It says Title II does not apply to employers with fewer than 15 employees. It also says the military may use genetic information in employment decisions, and that TRICARE may not use genetic information for coverage, underwriting, or premium decisions, while eligibility for TRICARE depends on military employment. A life insurer, a disability insurer, or a long-term care insurer can still ask about a test. GINA does not stop that ask.

References: DOL: Genetic Information Nondiscrimination Act questions for group health plans · National Human Genome Research Institute: What GINA covers and what it does not

How do I appeal a genetic testing denial?

Follow the notice. Ask the ordering clinician for a statement that matches the reason on the denial: why the test is medically necessary, what decision the result would change, and, if the plan required an approval, when that request was made. A prior-authorization denial is not fixed by relabeling the test as preventive unless you are in the BRCA population above and the rest of that rule applies. See a prior authorization denial and a health insurance appeal letter. The deadline is on the notice. The usual private-plan clocks are in health insurance appeal deadlines.

If the laboratory is out of network, ask the plan whether an in-network laboratory can perform the same test, and whether the plan will consider a single-case agreement. The plan does not have to agree. See an out-of-network medical bill. If the notice offers an external review after the plan's appeal, or says the dispute is a medical judgment, that review is in how to request an external review. Original Medicare does not use this private-plan appeal. A denial on a Medicare Summary Notice uses the redetermination on that notice. See how to appeal an Original Medicare denial. This page does not state Medicare's coverage criteria for a particular genetic test. Use the reason on your notice. A Part D drug appeal is for a drug at a pharmacy, not for a laboratory test. See a prescription drug the plan will not cover only if the denial is about a drug.

References: HealthCare.gov: Internal appeals · USPSTF: BRCA-related cancer risk assessment, genetic counseling, and genetic testing

What this page cannot promise

This is general information, not medical or legal advice. A plan can find that you are outside the BRCA recommendation, that the provider was out of network, or that the test was not medically necessary. GINA does not require payment and does not cover life, disability, or long-term care insurance. An appeal can be denied. Nothing on this page promises that a plan will pay for genetic testing or that a laboratory will cancel a bill.

Sources and further help

These sources provide general guidance. For a deadline or requirement that applies to you, follow your plan’s notice or the appropriate program’s current instructions.

Insurer websites may ask you to select your state or sign in. If a page will not open, use the member services number on your insurance card and ask for the current appeal instructions for your plan.

Report a broken link or suggest a correction.

← Explore all 141 guides